FDA Registration
Active
🇺🇸 United States
ACESO LABORATORIES INC.
Reg #: 3024463179
·
FEI: 3024463179
·
Expires 2026
Products
58
Proprietary Names
52
Establishment Types
1
Classifications
58
Registration Details
- Registration Name
- ACESO LABORATORIES INC.
- Registration Number
- 3024463179
- FEI Number
- 3024463179
- Status
- Active
- Expiry Year
- 2026
- Initial Importer
- No
- Address
- 14020 Central Ave, Suite 520
- City
- Chino
- State
- CA
- ZIP
- 91710
- Country
- US
Regulatory Submissions
- 510(k) Number
- K242576
Owner / Operator
- Firm Name
- Aceso Laboratories Inc.
- Operator Number
- 10085983
- Address
- 14020 Central Ave, Suite 520
- City
- Chino
- State
- CA
- Postal Code
- 91710
- Country
- US
Products
| Device Name | Product Code | Device Class | Medical Specialty | Exempt | Created |
|---|---|---|---|---|---|
| Culture Media, Non-Propagating Transport | JSM | Class 1 | Microbiology | No | 2025-05-14 |
| Lactoferrin, Antigen, Antiserum, Control | DEG | Class 1 | Immunology | No | 2024-05-13 |
| Test, Cannabinoid, Over The Counter | NFW | Class 2 | Clinical Toxicology | No | 2025-05-14 |
| Test, Cocaine And Cocaine Metabolites, Over The Counter | NFY | Class 2 | Clinical Toxicology | No | 2025-05-14 |
| Test, Amphetamine, Over The Counter | NFT | Class 2 | Clinical Toxicology | No | 2025-05-14 |
| Test, Opiates, Over The Counter | NGL | Class 2 | Clinical Toxicology | No | 2025-05-14 |
| Test, Morphine, Over The Counter | NGI | Class 2 | Clinical Toxicology | No | 2025-05-14 |
| Test, Benzodiazepine, Over The Counter | NFV | Class 2 | Clinical Toxicology | No | 2025-05-14 |
| Test, Barbiturate, Over The Counter | PTH | Class 2 | Clinical Toxicology | No | 2025-05-14 |
| Test, Propoxyphene, Over The Counter | QBF | Class 2 | Clinical Toxicology | No | 2025-05-14 |
| Test, Tricyclic Antidepressants, Over The Counter | QAW | Class 2 | Clinical Toxicology | No | 2025-05-14 |
| Test, Methadone, Over The Counter | PTG | Class 2 | Clinical Toxicology | No | 2025-05-14 |
| Test, Phencyclidine (Pcp), Over The Counter | NGM | Class U | Unknown | No | 2025-05-14 |
| Test, Methamphetamine, Over The Counter | NGG | Class 2 | Clinical Toxicology | No | 2025-05-14 |
| Test, Luteinizing Hormone (Lh), Over The Counter | NGE | Class 1 | Clinical Chemistry | No | 2024-07-24 |
| Kit, Test, Pregnancy, Hcg, Over The Counter | LCX | Class 2 | Clinical Chemistry | No | 2024-05-10 |
| Norovirus Serological Reagent | OUC | Class 2 | Microbiology | No | 2024-05-13 |
| Enzyme Immunoassay, Opiates | DJG | Class 2 | Clinical Toxicology | No | 2024-05-10 |
| Antiserum, Vibrio Cholerae, All Varieties | GSQ | Class 2 | Microbiology | No | 2024-05-13 |
| Azo-Dyes, Colorimetric, Bilirubin & Its Conjugates (Urinary, Non-Quant.) | JJB | Class 1 | Clinical Chemistry | No | 2024-05-13 |
| Immunoassay, Insulin-Like Growth Factor Binding Protein-1 | OAM | Class 1 | Clinical Chemistry | No | 2024-05-13 |
| Diazonium Colorimetry, Urobilinogen (Urinary, Non-Quant.) | CDM | Class 1 | Clinical Chemistry | No | 2024-05-13 |
| Antigens, All Groups, Salmonella Spp. | GRL | Class 2 | Microbiology | No | 2024-05-13 |
| Antigens, Cf, All, Mycoplasma Spp. | GSB | Class 1 | Microbiology | No | 2024-05-13 |
| Antigens, All Groups, Streptococcus Spp. | GTY | Class 1 | Microbiology | No | 2024-05-13 |
| Test, Urine Leukocyte | LJX | Class 1 | Hematology | No | 2026-03-18 |
| Diazo (Colorimetric), Nitrite (Urinary, Non-Quant) | JMT | Class 1 | Clinical Chemistry | No | 2026-03-18 |
| Antigen, Id, Ha, Cep, Entamoeba Histolytica & Rel. Spp. | KHW | Class 2 | Microbiology | No | 2024-05-13 |
| Antigens (Febrile), Agglutination, Brucella Spp. | GSO | Class 2 | Microbiology | No | 2024-05-13 |
| Enzyme Immunoassay, Amphetamine | DKZ | Class 2 | Clinical Toxicology | No | 2024-05-10 |
| Enzyme Immunoassay, Phencyclidine | LCM | Class U | Unknown | No | 2024-05-10 |
| Enzyme Immunoassay, Cocaine And Cocaine Metabolites | DIO | Class 2 | Clinical Toxicology | No | 2024-05-10 |
| Enzyme Immunoassay, Methadone | DJR | Class 2 | Clinical Toxicology | No | 2024-05-10 |
| Thin Layer Chromatography, Methamphetamine | DJC | Class 2 | Clinical Toxicology | No | 2024-05-10 |
| Enzyme Immunoassay, Barbiturate | DIS | Class 2 | Clinical Toxicology | No | 2024-05-10 |
| Thin Layer Chromatography, Morphine | DNK | Class 2 | Clinical Toxicology | No | 2024-05-10 |
| Gas Chromatography, Methamphetamine | LAF | Class 2 | Clinical Toxicology | No | 2024-05-10 |
| Enzyme Immunoassay, Benzodiazepine | JXM | Class 2 | Clinical Toxicology | No | 2024-05-10 |
| Enzyme Immunoassay, Cannabinoids | LDJ | Class 2 | Clinical Toxicology | No | 2024-05-10 |
| Radioimmunoassay, Tricyclic Antidepressant Drugs | LFG | Class 2 | Clinical Toxicology | No | 2024-05-10 |
| Enzyme Linked Immunoabsorbent Assay, Rotavirus | LIQ | Class 1 | Microbiology | No | 2024-05-13 |
| Giardia Spp. | MHI | Class 2 | Microbiology | No | 2024-05-13 |
| Indicator Method, Protein Or Albumin (Urinary, Non-Quant.) | JIR | Class 1 | Clinical Chemistry | No | 2024-05-13 |
| Dye-Indicator, Ph (Urinary, Non-Quantitative) | CEN | Class 1 | Clinical Chemistry | No | 2024-05-13 |
| Test System, Nicotine, Cotinine, Metabolites | MRS | Class 1 | Clinical Toxicology | No | 2024-05-13 |
| Reagents, Antibody, Legionella, Direct & Indirect Fluorescent | LHL | Class 2 | Microbiology | No | 2024-05-13 |
| Radioimmunoassay, Luteinizing Hormone | CEP | Class 1 | Clinical Chemistry | No | 2022-10-07 |
| Reagents, Clostridium Difficile Toxin | LLH | Class 1 | Microbiology | No | 2024-05-13 |
| Automated Urinalysis System | KQO | Class 1 | Clinical Chemistry | No | 2024-05-13 |
| Albumin, Antigen, Antiserum, Control | DCF | Class 2 | Immunology | No | 2024-05-13 |
| Nitroprusside, Ketones (Urinary, Non-Quant.) | JIN | Class 1 | Clinical Chemistry | No | 2024-05-13 |
| Cryptosporidium Spp. | MHJ | Class 2 | Microbiology | No | 2024-05-13 |
| Antigens, Cf (Including Cf Control), Adenovirus 1-33 | GOD | Class 1 | Microbiology | No | 2024-05-13 |
| Antigen, Id, Candida Albicans | LHK | Class 2 | Microbiology | No | 2024-05-13 |
| Visual, Pregnancy Hcg, Prescription Use | JHI | Class 2 | Clinical Chemistry | No | 2024-05-10 |
| Device, General Purpose, Microbiology, Diagnostic | LIB | Class 1 | Microbiology | No | 2024-05-13 |
| Antigens, All, Leptospira Spp. | GRY | Class 2 | Microbiology | No | 2024-05-13 |
| Seminal Fluid, Antigen, Antiserum, Control | DGB | Class 1 | Immunology | No | 2024-05-13 |
Proprietary Names
Atida Viral Transport Medium
Lactoferrin Test
Atida Multiplex Drug of Abuse Test Cup
Atida Multiplex Drug of Abuse Cup Test
LH Ovulation Test
Atida Pregnancy Test
Norovirus Test
Atida Fentanyl Drug of Abuse Test Rx
Vibrio cholerae O139 (VC O139) Test
Vibrio cholerae O1/O139 Combo Test
Vibrio cholerae O1 (VC O1) Test
Urinalysis Reagent Strips - 1-14 parameters
Insulin-like Growth Factor-binding Protein 1 (iGFBP-1) Test
Typhoid IgG/IgM Test
Salmonella typhi Ag Test
Mycoplasma pneumoniae Ag Test
Strep A Test
Atida Fentanyl Test
Atida Fentanyl Drug of Abuse Test
Atida Urinary Tract Infection Test
Entamoeba histolytica Test
Brucella Abortus Ag Test
ACESO Early Pregnancy Test
Atida Early Pregnancy Test
Atida Multiplex Drug of Abuse Dip Card Test Rx
Atida Multiplex Drug of Abuse Dip Card Test
Atida Multiplex Drug of Abuse Cup Test Rx
Rotavirus & Adenovirus Combo Test
Rotavirus Test
Giardia Lamblia Test
Vaginal pH Test
Atida Digital Pregnancy Test
Cotinine (COT) Test
Legionella pneumophila Test
Clostridium difficile Toxin A &Toxin B Combo Test
Micro-Albumin Semi-Quantitative Test
Micro-Albumin Test
Urinalysis Reagent Strips -1-14 parameters
Cryptosporidium Test
Adenovirus Test
Atida Multiplex Drug of Abuse Rapid Urine Cup Test
Atida Multiplex Drug of Abuse Urine Cup Test
Atida Digital Early Pregnancy Test
Candida albicans Test
Atida hCG Pregnancy Rapid Combo Test
Atida Single Drug Drug of Abuse Strip Test
Atida Single Drug Drug of Abuse Strip Test Rx
Filariasis IgG/IgM Test
Leptospira IgG/IgM Test
Atida Multiplex Drug of Abuse Rapid Urine Dip Card Test
Atida Multiplex Drug of Abuse Urine Dip Card Test
Human Semen Test
Establishment Types
Manufacture Medical Device